Past Podcast Episodes

Gender Differences & MS

My guest this week is Dr. Rhonda Voskuhl, Director of the Multiple Sclerosis Program at the David Geffen School of Medicine at UCLA and the Jack H. Skirball professor of Multiple Sclerosis Research. Dr. Voskuhl is responsible for first identifying that understanding the gender differences in the disease is an important part of understanding MS. This is one of my favorite interviews, and it's packed with great information.

Dr. Rhonda Voskuhl

We're also talking about the potential of data and technology to improve care for people living with MS, how MS and depression can lead to high rates of Alexithymia among people living with MS, how recognizing non-traditional MS symptoms can lead to getting an MS diagnosis years earlier, and an opportunity for African-Americans with MS to participate in a UCSF study.

We have a lot to talk about! Are you ready for RealTalk MS?

____________

MS + Depression or Anxiety = High Rates of Alexithymia 2:04

MS Society U.K. Commissions Report on the Potential of Data and Technology to Improve Care for People Living with MS 4:13

U.K.'s National Health Service Announces New App 9:18

Recognizing Non-Traditional Symptoms Can Lead to MS Diagnosis Years Earlier 11:34

UCSF Recruiting African-Americans with MS for Study 14:24

Interview with Dr. Rhonda Voskuhl 17:01

___________

LINKS
If your podcast app doesn't show these links, you'll find them in the show notes at www.RealTalkMS.com

International Progressive MS Alliance

High Levels of Alexithymia in Patients with Multiple Sclerosis

Improving Care for People with MS: The Potential of Data & Technology

New NHS App Will Make It Quciker & Easier to Access Health Services

Five Years Before MS Onset: Phenotyping the Prodrome

Email Address for UCSF Study is msdb@ucsf.edu

Give RealTalk MS a Rating & Review

___________

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 44
Hosted By: Jon Strum
Guest: Dr. Rhonda Voskuhl

Tags: MS, MultipleSclerosis, MSResearch, ProgressiveMS, mssocietyuk, UCLANeurology, UCSFMedicine, RealTalkMS

Episode 43: Cannabis & MS

Using cannabis to treat MS symptoms has become a hot topic. And thanks to social media, a lot of opinions about cannabis and MS are posted as if they're facts…and that's not always the case. So, we're talking about cannabis and MS in this episode of RealTalk MS. We'll try to demystify it a bit and we'll give you an idea of what some of the research is telling us. We'll talk about which MS symptoms cannabis might be good for…and which ones it might not be good for.

We're also talking about the latest reason that your health insurance premium is likely to rise in 2019 in the U.S., we'll walk you through “Clinical Trials 101” and explain what each phase of a clinical trial is really all about, and we'll give you the latest update on Ocrevus being rejected as a treatment for PPMS in the U.K.

We have a lot to talk about! Are you ready for RealTalk MS?

____________

U.S. Suspends Payments to Health Insurers 1:47

Everything You Always Wanted To Know About Clinical Trials 8:25

Clinical Trial to Track Urinary Symptoms in MS Is Recruiting Participants 15:05

NICE Rejects Ocrevus for PPMS 16:47

Cannabis & MS 19:04

___________

LINKS
If your podcast app doesn't show these links, you'll find them in the show notes at www.RealTalkMS.com

U.S. Suspends Payments to Health Insurers

Become an MS Activist

National MS Society Brochure on Participating in a Clinical Trial